|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/00 | |
| A61K 45/00 | |||
| A61P 17/06 | |||
| C07K 16/28 |
| (11) | Number of the document | 3185902 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15835936.4 |
| Date of filing the European patent application | 2015-08-26 | |
| (97) | Date of publication of the European application | 2017-07-05 |
| (45) | Date of publication and mention of the grant of the patent | 2020-07-29 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/JP2015/004306 |
| Date | 2015-08-26 |
| (87) | Number | WO 2016/031250 |
| Date | 2016-03-03 |
| (30) | Number | Date | Country code |
| 201462041862 P | 2014-08-26 | US |
| (72) |
NAKAGAWA, Hidemi, JP
MATSUDO, Hiroki, JP
|
| (73) |
Amgen K-A, Inc.,
One Amgen Center Drive, Thousand Oaks, CA 91320-1799,
US
|
| (54) | METHOD FOR TREATING PSORIASIS PATIENT WHICH RECEIVED ANTI-TNF-ALPHA ANTIBODY THERAPY |
| METHOD FOR TREATING PSORIASIS PATIENT WHICH RECEIVED ANTI-TNF-ALPHA ANTIBODY THERAPY |